openPR Logo
Press release

Acquired (Autoimmune) Hemolytic Anemia Market Novartis, Sanofi, Hoffmann-La Roche, Agios Pharmaceuticals in 2017 - 2025

Acquired (Autoimmune) Hemolytic Anemia Market Novartis,

Hemolytic anemia is a diseased condition characterized by premature destruction of red blood cells (RBCs) and their removal from the blood circulatory system before their life span is over. Red blood cells also known as erythrocytes are disk like structures that carry oxygen from lungs to body organs and help in removing carbon dioxide from the body. Usually red blood cells (RBCs) have a normal life span of 120 before they are removed from the blood stream by spleen. Red blood cells are produced by bone marrow. In people suffering from acquired (autoimmune) hemolytic anemia, bone marrows are unable to produce enough RBCs to meet body’s demand. Acquired (autoimmune) hemolytic anemia is non-genetic in nature and usually occurs when the body’s own immune system destroys its healthy tissues against invading organisms such as lymphocytes and antibodies. Acquired (autoimmune) hemolytic anemia generally occurs as a result or in conjunction with some other medical conditions. This condition rarely occurs alone. Acquired (autoimmune) hemolytic anemia can be classified as warm antibody hemolytic anemia and cold antibody hemolytic anemia. In warm antibody hemolytic anemia, auto-antibodies attach with the red blood cells and kill them at temperature higher than the body temperature; conversely, in cold antibody hemolytic anemia self-generated antibodies kill red blood cells at a temperature below the body temperature.

Free Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/11528

Diagnosis involves a range of blood tests such as hemoglobin and hematocrit test, bilirubin test, serum haptoglobin test and reticulocyte count. If the ratio is high, there is likeliness of hemolytic anemia. Coombs test is another key diagnostic method for acquired (autoimmune) hemolytic anemia in which the amount of certain antibodies is determined in order to check if it is higher than normal. Treatment is based on three major aims, preventing the destruction of RBCs, increasing the RBCs count and treating the origin of illness. Blood transfusion, medications, plasmapheresis and surgeries are among major treatment options. Prednisone, rituximab, hydroxyurea and cyclosporine are some drugs that are usually prescribed for treating acquired (autoimmune) hemolytic anemia.

There are no exact incidence and prevalence statistics are available regarding the acquired (autoimmune) hemolytic anemia. According to sources from Elsevier, Inc. the incidence rate of all types of acquired (autoimmune) hemolytic anemias range from one new case per 100,000 general population to 300,000 per year. Though the prevalence is not so high, severity of the condition will play a key role in driving the market growth. The market will also be driven by unmet medical needs as there is no standard medicines available for treating acquired hemolytic anemia. Many companies are conducting clinical trials in order to introduce effective medicines for acquired hemolytic anemia. Some major pharmaceutical companies and research institutions that are engaged in the development, manufacturing and marketing of drugs for this market include Novartis AG, Sanofi, Centre Hospitalier Universitaire Dijon, Institute of Hematology & Blood Diseases Hospital, Hoffmann-La Roche, National Cancer Institute (NCI), Agios Pharmaceuticals, Inc., Octapharma Pharmazeutika Produktionsges.m.b.H., National Heart, Lung, and Blood Institute (NHLBI) and Baxter Healthcare Corporation.

Geographically, the acquired (autoimmune) hemolytic anemia market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). Globally, the market is led by North America, followed by Europe, Asia-Pacific and Rest of the World (RoW). High level of awareness, high per capita income and well established reimbursement scenario are among the major factors responsible for North America’s leading position in the acquired (autoimmune) hemolytic anemia market.

MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

Request For TOC of Report @ https://www.marketresearchreports.biz/sample/toc/11528

The report provides the following information:

Tailwinds and headwinds molding the market’s trajectory
Market segments based on products, technology, and applications
Prospects of each segment
Overall current and possible future size of the market
Growth pace of the market
Competitive landscape and key players’ strategies

The main aim of the report is to:

Enable key stakeholder’s in the market bet right on it
Understand the opportunities and pitfalls awaiting them
Assess the overall growth scope in the near term
Strategize effectively with respect to production and distribution

MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: https://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acquired (Autoimmune) Hemolytic Anemia Market Novartis, Sanofi, Hoffmann-La Roche, Agios Pharmaceuticals in 2017 - 2025 here

News-ID: 1718376 • Views: 228

More Releases for RBCs

Complete Blood Count (CBC) Market Analysis Reveals explosive growth by 2023 | An …
The demand for Complete Blood Count (CBC) Market is anticipated to be high for the next few years. By considering this demand we provide latest Complete Blood Count (CBC) Market Report which gives complete industry analysis, market outlook, size, growth and forecast till 2023. This report will assist in analyzing the current and future business trends, sales and revenue forecasts. Global Complete Blood Count (CBC) Market Overview: This report studies the Global
Biopreservation Market Competitive Landscape 2017-2025 : Cesca Therapeutics Inc. …
The global market for biopreservation is predicted to witness a highly positive growth trajectory in the coming years, according to TMR Research. The market research company’s published report, titled, “Biopreservation Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” indicates that the surging expenditures on healthcare, the trend of conserving cord blood stem cells, along with the rising amount of investments in research and
Nanobots Pave Way For The Development Of Artificial Antibodies, Artificial RBCs …
The emerging technology of nanobots offers better chances of fighting chronic diseases such as cancer. Moreover, further developments in nanomedicine market can create opportunities such as the development of artificial antibodies and artificial RBCs and WBCs. Nanomedicine is a domain of medicine that utilizes the knowledge of nanotechnology to prevent and treat severe diseases such as cancer and heart diseases. The recent advances in nanotechnology have enabled doctors to use
Blood Products Market Size, Share, Trends, Growth, Analysis Latest Report By Key …
The latest report published on Up Market Research, on Blood Products Market Analysis offers comprehensive analysis, delivering detailed market data and penetrating insights. The report covers detailed Blood Products Market analysis by Product, Application, Region, Major Player, Market Size, Share, Trends, Growth and Forecast 2018-2023. The Blood Products Market report published on Up Market Research is spread across 123 pages and provides an overview of the 2018-2023 of Blood Products Market
Acquired (Autoimmune) Hemolytic Anemia Market Significant Profits Estimated to b …
Hemolytic anemia is a diseased condition characterized by premature destruction of red blood cells (RBCs) and their removal from the blood circulatory system before their life span is over. Red blood cells also known as erythrocytes are disk like structures that carry oxygen from lungs to body organs and help in removing carbon dioxide from the body. Usually red blood cells (RBCs) have a normal life span of 120 before
Recent Study:Acquired (Autoimmune) Hemolytic Anemia to Represent an Impressive C …
Hemolytic anemia is a diseased condition characterized by premature destruction of red blood cells (RBCs) and their removal from the blood circulatory system before their life span is over. Red blood cells also known as erythrocytes are disk like structures that carry oxygen from lungs to body organs and help in removing carbon dioxide from the body. Usually red blood cells (RBCs) have a normal life span of 120 before